These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9504896)

  • 1. Review: Present and future directions in the treatment of chronic hepatitis B infection.
    Nicoll A; Locarnini S
    J Gastroenterol Hepatol; 1997 Dec; 12(12):843-54. PubMed ID: 9504896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical potential of emerging new agents in hepatitis B.
    Farrell GC
    Drugs; 2000 Oct; 60(4):701-10. PubMed ID: 11085196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus: old, new and future approaches to antiviral treatment.
    Karayiannis P
    J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus kinetics and mathematical modeling.
    Perelson AS; Ribeiro RM
    Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment modalities for hepatitis B viral infection and resistance to antiviral therapy.
    Pai SB; Pai RB; Schinazi RF
    Panminerva Med; 2003 Sep; 45(3):165-73. PubMed ID: 14618114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral therapy and resistance with hepatitis B virus infection.
    Tillmann HL
    World J Gastroenterol; 2007 Jan; 13(1):125-40. PubMed ID: 17206760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
    Zoulim F
    Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
    Papatheodoridis GV; Dimou E; Papadimitropoulos V
    Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of anti-HBV chemotherapy.
    Hong JH; Choi Y; Chun BK; Lee K; Chu CK
    Arch Pharm Res; 1998 Apr; 21(2):89-105. PubMed ID: 9875415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel treatment options for hepatitis B virus infection.
    Kumar R; Agrawal B
    Curr Opin Investig Drugs; 2004 Feb; 5(2):171-8. PubMed ID: 15043391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antivirals for the treatment of chronic hepatitis B: current and future options.
    Humphries JC; Dixon JS
    Intervirology; 2003; 46(6):413-20. PubMed ID: 14688461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral chemotherapy for the treatment of hepatitis B virus infections.
    Torresi J; Locarnini S
    Gastroenterology; 2000 Feb; 118(2 Suppl 1):S83-103. PubMed ID: 10868900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective.
    Lau GK; Carman WF; Locarnini SA; Okuda K; Lu ZM; Williams R; Lam SK
    J Gastroenterol Hepatol; 1999 Jan; 14(1):3-12. PubMed ID: 10029271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis B.
    Lai CL; Ratziu V; Yuen MF; Poynard T
    Lancet; 2003 Dec; 362(9401):2089-94. PubMed ID: 14697813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: Nucleoside analogues for the treatment of chronic hepatitis B.
    Younger HM; Bathgate AJ; Hayes PC
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1211-30. PubMed ID: 15606384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of multi-drug resistant hepatitis B virus during sequential therapy.
    Yim HJ; Hussain M; Liu Y; Wong SN; Fung SK; Lok AS
    Hepatology; 2006 Sep; 44(3):703-12. PubMed ID: 16941700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.